Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative effectiveness and safety of branded and generic apixaban among patients with atrial fibrillation in Thailand
TCTR20250307002Phase 4Not yet recruiting
- Sponsor
- Community Pharmacy
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by Community Pharmacy. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20250307002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250307002.